GE HealthCare TechnologiesMEX:GEHC 63 PS Ratio is 1.37 as of Jul. 04, 2026, which is 24% below its 10-year median of 1.81. GuruFocus rates MEX:GEHC with a GF Score™ of 63/100 and a GF Value™ of MXN1,493.20 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 805 Medical Devices & Instruments companies, GE HealthCare Technologies ranks better than 72.3% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, GE HealthCare Technologies's share price is MXN1149.89.
GE HealthCare Technologies's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was MXN838.76. Hence, GE HealthCare Technologies's PS Ratio for today is 1.37.
Good Sign:
GE HealthCare Technologies Inc stock PS Ratio (=1.43) is close to 5-year low of 1.33.
The historical rank and industry rank for GE HealthCare Technologies's PS Ratio or its related term are showing as below:
MEX:GEHC'
s PS Ratio Range Over the Past 10 Years
Min: 1.33 Med: 1.81 Max: 2.2
Current: 1.43
During the past 7 years, GE HealthCare Technologies's highest PS Ratio was 2.20. The lowest was 1.33. And the median was 1.81.
MEX:GEHC's PS Ratio is ranked better than 72.3% of 805
companies
in the Medical Devices & Instruments industry
Industry Median: 2.94
vs MEX:GEHC: 1.43
During the past 7 years, GE HealthCare Technologies's highest 3-Year average Revenue per Share Growth Rate was 4.20% per year. The lowest was 3.40% per year. And the median was 3.60% per year.
Back to Basics: PS Ratio
GE HealthCare Technologies (MEX:GEHC) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
GE HealthCare Technologies PS Ratio Related Terms
GE HealthCare Technologies PS Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, GE HealthCare Technologies's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
GE HealthCare Technologies PS Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, GE HealthCare Technologies's PS Ratio distribution charts can be found below:
* The bar in red indicates where GE HealthCare Technologies's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
GE HealthCare Technologies's Share Price of today is MXN1149.89. GE HealthCare Technologies's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN838.76.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
GE HealthCare Technologies (MEX:GEHC) has a PS Ratio of 1.37 as of Jul. 04, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on GE HealthCare Technologies and its competitors. This is 24% below median its historical median of 1.81. Over the past decade, GE HealthCare Technologies' PS Ratio has ranged from 1.33 to 2.20. According to the industry distribution chart, GE HealthCare Technologies ranks #223 out of 805 companies in the Medical Devices & Instruments industry, placing it in the top 27.7%.
Is GE HealthCare Technologies' PS Ratio too high?
GE HealthCare Technologies' current PS Ratio of 1.37 is 24% below median its 10-year median of 1.81. Over the past 10 years, this metric has ranged from a low of 1.33 to a high of 2.20. The Medical Devices & Instruments industry median PS Ratio is 2.94. GE HealthCare Technologies' value of 1.37 is 53.4% below this industry median. Based on the distribution chart, GE HealthCare Technologies ranks #223 out of 805 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, GE HealthCare Technologies has a GF Score™ of 63/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does GE HealthCare Technologies' PS Ratio compare to DXCM and STE?
According to the Medical Devices & Instruments industry distribution chart, GE HealthCare Technologies ranks #223 out of 805 companies for PS Ratio. This puts GE HealthCare Technologies in the upper half of its industry. The industry median PS Ratio is 2.94. GE HealthCare Technologies' value of 1.37 is 53.4% below this benchmark. Historically, GE HealthCare Technologies' own PS Ratio has ranged from 1.33 to 2.20 over the past decade. While the company's 10-year median is 1.81 vs. the industry median of 2.94, GE HealthCare Technologies has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Medical Devices & Instruments company?
The median PS Ratio among Medical Devices & Instruments companies is 2.94, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. GE HealthCare Technologies's current PS Ratio of 1.37 is 53.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on GE HealthCare Technologies and its competitors. For the Medical Devices & Instruments industry, the median PS Ratio is 2.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. GE HealthCare Technologies's current PS Ratio is 1.37, which is 24% below median its own 10-year median of 1.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GE HealthCare Technologies stock overvalued right now?
Based on GuruFocus' analysis, GE HealthCare Technologies (MEX:GEHC) is currently considered Modestly Undervalued. The stock's GF Value™ is MXN1,493.20, compared to a current price of MXN1,149.89 — trading 23% below its estimated fair value. The current PS Ratio is 1.37, which is 24% below median its 10-year median of 1.81 and 53.4% below the Medical Devices & Instruments industry median of 2.94. GE HealthCare Technologies' overall GF Score™ is 63/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For GE HealthCare Technologies (MEX:GEHC), the current PS Ratio is 1.37 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is GE HealthCare Technologies (MEX:GEHC) Overvalued in 2026?
Based on GuruFocus' analysis, GE HealthCare Technologies stock appears to be undervalued.
The current stock price of MXN1,149.89 is trading 23% below its estimated GF Value™ of MXN1,493.20.
GuruFocus considers GE HealthCare Technologies to be Modestly Undervalued.
Key valuation signals for MEX:GEHC:
PS Ratio: 1.37 (24% below median its 10-year median of 1.81)
GF Value™: MXN1,493.20 vs. price of MXN1,149.89 (23% below fair value)
Industry Position: 53.4% below the Medical Devices & Instruments median (#223 of 805)
No single metric tells the full story. See the MEX:GEHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).
63GF Score
Get the complete analysis for MEX:GEHC
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:GEHC has been successfully added to your 
